Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1177 - 1184 of 11616 results
FTC Pharma Merger Digest May Offer Policy Clues
June 15, 2023| News
New AI Disclosure Bill and AI Strategic Plan Update — AI: The Washington Report
June 13, 2023| Article| Viewpoint
PE Firms Get Creative With Add-on Deal Structures
June 13, 2023| News
Mintz's New Women Members
June 11, 2023| Article| Viewpoint
One Year at the Crossroads of Women’s Health and Technology
June 11, 2023| Article| Viewpoint
Preeminent Litigator Discusses the Importance of Leading Through Service
June 11, 2023| Article| Viewpoint
Toronto Women Partners Accelerate Cross-Border Reach in Life Sciences, Technology, and Private Equity
June 11, 2023| Article| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.